Project Grant R44MH136867
Award Date
4/3/25
Completion Date
3/31/26
Dollars Obligated
$380K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The federal Project Grant award for $2,651,252.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports the commercialization readiness of Nous Imaging, Inc.'s Framewise Integrated Real-time MRI Monitoring (FIRMM) software solution. FIRMM is an FDA-cleared technology that mitigates data loss due to patient motion during MRI scans, addressing an estimated $4B annual healthcare cost. The goal of this award is to partner with...
The National Institute of Mental Health (NIMH) awarded a $156,656 Project Grant (CFDA 93.242 Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "ADVANCED FUNCTIONAL MRI OF CEREBRAL CORTICAL LAYERS IN THE HUMAN BRAIN USING ULTRAHIGH-RESOLUTION LINESCAN MRI TECHNOLOGY". The project aims to advance "linescan fMRI" technology to enable high-resolution mapping of brain activity across...
This $1,596,935 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports the commercialization of Petcoil, Inc.'s portable, brain-dedicated positron emission tomography (PET) insert system that can be used in existing magnetic resonance imaging (MRI) machines. The goal is to develop a lower-cost solution for simultaneous PET/MRI brain imaging compared to current permanently-integrated PET/MRI systems, which...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, was awarded to Intelligent Imaging Innovations, Inc. (3i) to establish the feasibility of developing a commercial instrument for large-scale, all-optical electrophysiology. The $505,311 award, spanning January 1, 2025 to December 31, 2026, seeks to combine recent advancements in optical techniques, such as volumetric imaging of neural activity and...
This $449,228 Project Grant, awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will fund the development of an integrated system for long-term electrophysiological profiling of human brain organoids. The key products to be delivered are:
A biological assay chamber that supports chronic electrophysiology while maintaining organoid health;
High-fidelity, 3D neural probes for chronic, extracellular recording and stimulation;...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $446,490 to Esperimage LLC to develop flexible and scalable photogrammetric head modeling tools to complement their wearable, high-fidelity optical brain imaging technology. The goal is to enable naturalistic brain imaging studies, particularly in children with autism spectrum disorder, to overcome the limitations of previous neuroimaging...
The National Institute of Mental Health (NIMH) awarded a $517,546 Project Grant (CFDA 93.242 Mental Health Research Grants) to Trustees of Dartmouth College to develop a novel multimodal microelectrode array (MEA) probe with integrated fast-scan cyclic voltammetry (FSCV) for sub-second neuromodulator sensing and parallel electrophysiological recording. This 5-year award, running from December 2024 to October 2029, aims to optimize, benchmark, and validate the EPHYS-FSCV MEA platform for...
The Project Grant award R43MH135772, totaling $300,691.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The award aims to advance Numentus Technologies Inc.'s high-speed hyperspectral imaging technology for highly multiplexed immunofluorescence imaging in pathology. The project will improve the company's technology to enable rapid, cost-effective detection of up to 12 molecular targets in a single tissue sample,...
The National Institute of Mental Health (NIMH) awarded a $560,641 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Psychogenics Inc. to develop an innovative drug repurposing platform using electroencephalogram (EEG) data. The goal is to create an EEG-based screening platform, called eCube, that can compare EEG signatures of reference drugs against animal models of rare diseases to rapidly identify potential drug repurposing opportunities. The Phase I proof-of-concept project...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants provides $1,315,183 to Quspin Inc., a woman-owned small business, to develop a wearable magnetoencephalography (MEG) system based on optically-pumped magnetometer (OPM) technology. The goal is to commercialize this innovative, non-invasive neuroimaging technology that offers improved cost-effectiveness, flexibility, and spatial resolution compared to traditional...